Rajasthan Cancels Licence of Distributor Linked to Spurious Oxytocin in Maternal Deaths
The Rajasthan drug control department cancelled the licence of a Kota-based pharmaceutical distributor for supplying spurious oxytocin injections linked to five maternal deaths after Caesarean sections in May. Laboratory tests found the injections lacked oxytocin, rendering them ineffective. The distributor showed discrepancies in procurement and sales records, raising concerns about unaccounted stock. The manufacturing licence of the Amritsar-based producer was also revoked. The World Health Organization has requested a report from the Union government on the case.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 30%, Centre 65%, Right 5%). Overall sentiment is negative (30/100). Lens Score 59/100 — moderate public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- news18— balanced framing, negative sentiment
- hindustantimes— balanced framing, negative sentiment
AI Analysis
The articles present a factual account focusing on regulatory actions without political framing. They include official statements from drug control authorities and hospital representatives, reflecting government and health sector perspectives. The coverage does not emphasize political blame or opposition views, maintaining a neutral stance centered on public health and regulatory compliance.
The tone across the articles is serious and factual, reflecting concern over maternal deaths and regulatory violations. The coverage is largely negative due to the health risks and fatalities involved but remains objective, focusing on investigation outcomes and official responses without sensationalism or emotive language.
How 2 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.